ORANGE COUNTY EARNINGS
Cortex Pharmaceuticals Inc.: The Irvine neuroscience company said it lost $1.3 million, or 14 cents a share, for the fiscal second quarter, compared with a net loss of $1.3 million, or 20 cents a share on fewer shares outstanding, a year earlier. The company’s revenue totaled $50,000 for the three months ended Dec. 31. No revenue was generated a year ago.
For the first six months, the company posted a net loss of $2.6 million, or 28 cents a share, up from a loss of $2.5 million, or 36 cents a share, a year ago. Revenue totaled $50,000, compared with no revenue in the first six months a year ago.
The company is developing drugs for neurological and psychiatric disorders.
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.